1 . What is one way to reduce the stigma for patients living with chronic pain? 2 . Gabapentin has mild-to-moderate benefit in the treatment of: 3 . Spinal manipulation has demonstrated improvements in pain and function when used: 4 . Which is a true statement about factors to record in the patient record? 5 . Which of the following tools assess pain, pain interference, functional components, and quality of life, and was created to assess management of chronic pain in primary care settings? 6 . Which is a true statement about screening patients for potential opioid misuse? 7 . Patients who are already being prescribed opioids for chronic pain who exhibit an active OUD should be: 8 . Which of the following is an example of an opioid-related risk factor appropriately influencing a treatment choice? 9 . One sign of an active OUD is: 10 . Which of the following statements is true regarding a diagnosis of OUD using DSM-5 criteria? 11 . Under the Controlled Substances Act, the federal government considers cannabis: 12 . The Drug Enforcement Administration has named recurring patterns that might indicate inappropriate controlled substances (CS) prescribing, including which of the following? 13 . Attention deficit hyperactivity disorder is characterized by: 14 . Optimal treatment for narcolepsy: 15 . A common instruction to the patient contained in a treatment agreement for provision of opioids (or another CS) is: 16 . Patients with OUD or other problems managing opioids who are tapered or suddenly discontinued from opioids non-collaboratively are at risk for: 18 . The following FDA-approved medications to treat OUD are: 20 . Which of the following is a measure to be enacted at a healthcare facility when diversion of CS by a healthcare worker is discovered?